Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmaco-Imaging Trial of MAS for ADHD in Youth With ASD
NCT06853665Phase 4Recruiting
- Start
- Feb 2026
- Primary completion
- Feb 2030
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of mixed salts of a single-entity amphetamine product extended-release capsules in attention deficit hyperactivity disorder (ADHD). Started Feb 2026; status: recruiting.
02
Drugs
mixed salts of a single-entity amphetamine product extended-release capsules
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT06853665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853665.